Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant anastrozole feasibility and efficacy trial in localized hormone receptor-positive low-proliferation breast cancer
RBR-5pygzhjPhase 2Recruiting
- Sponsor
- Hospital de Amor
- Start
- Jul 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of anastrozole in breast cancer, sponsored by Hospital de Amor. Primary endpoints: Feasibility of preoperative anastrozole and Efficacy of preoperative anastrozole. Started Jul 2022; status: recruiting.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on RBR-5pygzhj.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-5pygzhj.